GlassScriptPhysician profile
Kristin D Oates
NPI 1437445426
$3,838.65
in general payments reported to CMS, 2019-2025
17 companies · $3,294 in 2025
The $3,294 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $28.86 · 2022: $15.22 · 2023: $284 · 2024: $102 · 2025: $3,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $680.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,037.22 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $243.32 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $164.05 | 2023-2024 | Myfembree |
| Abbvie INC. | $66.63 | 2022-2023 | |
| Organon LLC | $65.25 | 2024-2025 | Nexplanon |
| Shield Therapeutics INC | $43.17 | 2024 | |
| Hologic Sales and Service, LLC | $36.07 | 2023-2025 | Thinprep 2000 Processor, Omni Hysteroscope, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $33.05 | 2025 | Gardasil 9 |
| Vertical Pharmaceuticals, LLC | $24.65 | 2019 | |
| Pfizer INC. | $22.26 | 2025 | |
| Dexcom, INC. | $19.63 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $16.24 | 2023 | Veozah |
| Amag Pharmaceuticals, INC. | $15.81 | 2019 | |
| Allergan, INC. | $14.94 | 2020 | |
| Ascend Therapeutics US, LLC | $13.20 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $12.13 | 2019 | |
| Roche Diagnostics Corporation | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Oates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.